Innovative Product Launches Bausch + Lomb continuously expands its product portfolio with new launches such as preservative-free eye drops, antibiotic treatments, and specialized therapies like Meibo for tear evaporation, indicating ongoing opportunities for targeted distribution and pharmacy partnerships.

Strategic Collaborations The company's recent partnerships with pharmaceutical and healthcare providers, including collaborations with pharmaceuticals Inc and Adexilis, open avenues for co-marketing, licensing agreements, and expanded market reach in both North America and Europe.

Technological Advancements Leveraging AI and machine learning collaborations to identify new oral drugs targeting eye health signals potential for integrating innovative technologies into product development and personalized medicine solutions.

Market Expansion With a global presence in nearly 100 countries and a broad product range including contact lenses, pharmaceuticals, and surgical devices, Bausch + Lomb offers multiple entry points for distribution partners and regional sales accelerators.

Financial Strength Generating between one and ten billion dollars in revenue, Bausch + Lomb's robust financial backing supports scaling efforts, strategic acquisitions, and investment into emerging eye health technologies and product lines.